Literature DB >> 11897308

Survival after bone-marrow transplantation.

Mats Remberger, Olle Ringdén.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11897308     DOI： 10.1016/S0140-6736(02)07926-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

Authors:  Frank Cichocki; Michael R Verneris; Sarah Cooley; Veronika Bachanova; Claudio G Brunstein; Bruce R Blazar; John Wagner; Heinrich Schlums; Yenan T Bryceson; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

2.  CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.

Authors:  Margaret L Green; Wendy M Leisenring; Hu Xie; Roland B Walter; Marco Mielcarek; Brenda M Sandmaier; Stanley R Riddell; Michael Boeckh
Journal:  Blood       Date:  2013-06-06       Impact factor: 22.113

3.  Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG.

Authors:  Amin T Turki; Nikolaos Tsachakis-Mück; Saskia Leserer; Pietro Crivello; Tobias Liebregts; Luisa Betke; Ferras Alashkar; Nils B Leimkühler; Mirko Trilling; Katharina Fleischhauer; Dietrich W Beelen
Journal:  Blood Adv       Date:  2022-01-11

4.  How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?

Authors:  Mohammad Vaezi; Amir Kasaeian; Maryam Souri; Faeze Soufiyan; Amir Shokri Boosjin; Seyed Amin Setarehdan; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.